Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
381 GBX | -3.54% | +28.28% | +8.09% |
May. 08 | MaxCyte Shares Rise Sharply After Q1 Results Beat | MT |
May. 08 | MaxCyte shares rise amid double-digit revenue increase | AN |
Financials (USD)
Sales 2024 * | 36.71M | Sales 2025 * | 46.64M | Capitalization | 516M |
---|---|---|---|---|---|
Net income 2024 * | -49M | Net income 2025 * | -43M | EV / Sales 2024 * | 9.98 x |
Net cash position 2024 * | 150M | Net cash position 2025 * | 120M | EV / Sales 2025 * | 8.49 x |
P/E ratio 2024 * |
-10.7
x | P/E ratio 2025 * |
-11.9
x | Employees | 143 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 93.79% |
Latest transcript on MaxCyte, Inc.
1 day | -3.54% | ||
1 week | +28.28% | ||
Current month | +29.15% | ||
1 month | +15.45% | ||
3 months | -1.04% | ||
6 months | +38.55% | ||
Current year | +8.09% |
Managers | Title | Age | Since |
---|---|---|---|
Maher Masoud
CEO | Chief Executive Officer | 49 | - |
Douglas Swirsky
DFI | Director of Finance/CFO | 54 | 23-03-26 |
James Brady
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Patrick Balthrop
BRD | Director/Board Member | 67 | 22-11-30 |
Art Mandell
BRD | Director/Board Member | 71 | 06-04-30 |
Will Brooke
BRD | Director/Board Member | 68 | 04-02-29 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.20% | 12 M€ | -.--% | - | |
0.06% | 0 M€ | 0.00% | - | |
0.04% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-09 | 381 | -3.54% | 4 066 |
24-05-08 | 395 | +36.21% | 180,810 |
24-05-07 | 290 | -2.36% | 31,191 |
24-05-03 | 297 | 0.00% | 71,099 |
24-05-02 | 297 | +0.68% | 2,487 |
Delayed Quote London S.E., May 09, 2024 at 05:55 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.09% | 516M | |
+8.07% | 219B | |
+7.87% | 185B | |
+12.75% | 135B | |
-1.60% | 62.21B | |
+4.88% | 51.01B | |
+11.59% | 51.28B | |
+2.71% | 41.85B | |
+4.90% | 37.02B | |
+23.75% | 31.27B |
- Stock Market
- Equities
- MXCT Stock